Ultralife Financials

ULBI Stock  USD 5.75  0.23  4.17%   
Based on the measurements of operating efficiency obtained from Ultralife's historical financial statements, Ultralife is performing exceptionally good at this time. It has a great probability to report excellent financial results in April. As of now, Ultralife's Net Debt is increasing as compared to previous years. The Ultralife's current Non Current Assets Total is estimated to increase to about 106.3 M, while Total Current Liabilities is projected to decrease to under 17.5 M. Key indicators impacting Ultralife's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.140.21
Way Down
Slightly volatile
Current Ratio5.154.37
Fairly Up
Pretty Stable
The essential information of the day-to-day investment outlook for Ultralife includes many different criteria found on its balance sheet. An individual investor should monitor Ultralife's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Ultralife.

Net Income

8.69 Million

  

Ultralife Stock Summary

Ultralife competes with Powell Industries, Kimball Electronics, Hayward Holdings, NVent Electric, and Energizer Holdings. Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company was incorporated in 1990 and is headquartered in Newark, New York. Ultralife Corp operates under Electrical Equipment Parts classification in the United States and is traded on NASDAQ Exchange. It employs 560 people.
Specialization
Industrials, Electrical Equipment & Parts
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS9038991025
CUSIP903899102
LocationNew York; U.S.A
Business Address2000 Technology Parkway,
SectorElectrical Equipment
IndustryIndustrials
BenchmarkDow Jones Industrial
Websitewww.ultralifecorporation.com
Phone315 332 7100
CurrencyUSD - US Dollar

Ultralife Key Financial Ratios

Ultralife Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets137.7M159.1M168.4M178.3M205.0M215.3M
Other Current Liab6.5M6.2M9.9M9.5M10.9M11.5M
Net Debt(9.3M)12.4M15.6M18.9M17.0M17.8M
Retained Earnings(47.6M)(47.8M)(48.0M)(40.8M)(36.7M)(38.5M)
Accounts Payable10.8M9.8M16.1M11.3M13.0M9.1M
Cash10.7M8.4M5.7M10.3M11.8M7.1M
Net Receivables21.1M20.2M27.8M31.8M36.5M38.4M
Inventory28.2M33.2M41.2M42.2M48.5M51.0M
Other Current Assets4.6M4.7M4.3M5.9M5.4M5.4M
Total Liab20.8M41.3M52.0M52.8M60.8M63.8M
Total Current Assets64.5M65.7M79.0M90.2M103.7M54.7M
Short Term Debt1.4M2.9M2.9M2.9M2.6M3.0M
Common Stock2.0M2.1M2.1M2.1M2.4M1.9M
Other Assets13.3M14.1M14.1M14.4M16.5M17.4M
Intangible Assets9.2M17.1M15.9M15.1M17.4M18.2M
Other Liab590K2.1M4.1M1.9M2.2M1.6M
Good Will27.0M38.2M37.4M37.6M43.2M25.2M
Net Tangible Assets83.0M89.8M62.4M62.9M72.4M74.5M

Ultralife Key Income Statement Accounts

202020212022202320242025 (projected)
Interest Expense436K242K951K2.0M1.8M1.3M
Total Revenue107.7M98.3M131.8M158.6M182.4M191.6M
Gross Profit29.2M24.6M29.4M39.2M45.1M47.3M
Operating Income1.2M(3.5M)(4.3M)9.5M10.9M11.4M
Ebit5.7M510K129K11.1M12.8M13.4M
Ebitda8.6M4.0M4.6M15.0M17.3M18.2M
Cost Of Revenue78.6M73.6M102.4M119.4M137.4M144.2M
Income Before Tax7.0M(151K)(446K)9.1M10.5M11.0M
Net Income5.2M(230K)(120K)7.2M8.3M8.7M
Income Tax Expense1.7M79K(326K)2.0M2.2M2.4M
Research Development5.9M6.8M7.1M7.5M8.7M6.4M
Minority Interest99K(4K)1K9K10.4K9.0K
Tax Provision1.7M79K(326K)1.5M1.8M1.9M
Net Interest Income(436K)(242K)(951K)(1.8M)(1.6M)(1.6M)

Ultralife Key Cash Accounts

202020212022202320242025 (projected)
Change To Inventory1.8M(1.3M)(8.7M)(943K)(1.1M)(1.1M)
Change In Cash3.2M(2.2M)(2.7M)4.6M4.1M4.3M
Free Cash Flow18.6M1.5M(2.9M)(623K)(716.5K)(752.3K)
Depreciation2.9M3.5M4.5M3.9M4.5M2.9M
Other Non Cash Items44K(1.5M)104K33K29.7K28.2K
Capital Expenditures3.1M2.8M1.7M2.6M2.3M2.7M
Net Income5.3M(230K)(120K)7.2M8.3M8.7M
End Period Cash Flow10.7M8.4M5.7M10.3M11.8M7.1M
Change To Netincome(17.8M)2.0M736K528K475.2K499.0K
Dividends Paid930K148K250K15K13.5K12.8K
Investments(3.0M)(26.3M)(1.7M)(1.8M)(1.6M)(1.7M)

Ultralife Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ultralife's current stock value. Our valuation model uses many indicators to compare Ultralife value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ultralife competition to find correlations between indicators driving Ultralife's intrinsic value. More Info.
Ultralife is rated first in return on equity category among its peers. It is rated third in return on asset category among its peers reporting about  0.62  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Ultralife is roughly  1.62 . As of now, Ultralife's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ultralife's earnings, one of the primary drivers of an investment's value.

Ultralife Systematic Risk

Ultralife's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ultralife volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on Ultralife correlated with the market. If Beta is less than 0 Ultralife generally moves in the opposite direction as compared to the market. If Ultralife Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ultralife is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ultralife is generally in the same direction as the market. If Beta > 1 Ultralife moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Ultralife Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ultralife's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Ultralife growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.002192)

As of now, Ultralife's Price Earnings To Growth Ratio is increasing as compared to previous years.

Ultralife March 18, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Ultralife help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ultralife. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ultralife based on widely used predictive technical indicators. In general, we focus on analyzing Ultralife Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ultralife's daily price indicators and compare them against related drivers.

Complementary Tools for Ultralife Stock analysis

When running Ultralife's price analysis, check to measure Ultralife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ultralife is operating at the current time. Most of Ultralife's value examination focuses on studying past and present price action to predict the probability of Ultralife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ultralife's price. Additionally, you may evaluate how the addition of Ultralife to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments